ARCHIVES

NIH Defines Misconduct

This article is from The Cancer Letter archive.

Vol. 20 No. 47 | December 9, 1994

Download PDF Visit The Full Archive

Related Articles

Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds

January 29, 2010

Study Finds Up To 12 Percent Of Specimens Misdiagnosed

October 28, 2005

Tempero, Johnson To Lead ASCO

March 28, 2003

NCI Resumes Clinical Education Grants

March 18, 1983

Successful Treatment by Community MDs Reducing Numbers Of Patients In Research, DCT Board Told; “We can Work With them,” Carbone Says

April 27, 1979

FDA Gives Accelerated Approval To Tykerb For Metastatic Breast Cancer

February 5, 2010